City of Hope has developed and fine-tuned HopeLLM, a generative AI platform leveraging extensive oncology datasets to streamline new patient onboarding, personalize clinical trial matching, and extract real-world data to accelerate cancer research. Meanwhile, Washington University researchers introduced Cirrus Resting State fMRI Software, an AI-powered brain mapping tool FDA-cleared to improve neurosurgical precision by reducing imaging times and increasing patient accessibility. Separately, MicroPure Genomics secured $1.25 million in NSF funding to advance its automated electro-hydrodynamic purification system, enhancing sample preparation efficiency in genomic research. These advances underscore AI's growing impact in healthcare operations and molecular diagnostics.